000 01294 a2200385 4500
005 20250516185441.0
264 0 _c20140929
008 201409s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0083374
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThomassen, Yvonne E
245 0 0 _aNext generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals.
_h[electronic resource]
260 _bPloS one
_c2013
300 _ae83374 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aChlorocebus aethiops
650 0 4 _aGuinea Pigs
650 0 4 _aMice
650 0 4 _aPoliomyelitis
_ximmunology
650 0 4 _aPoliovirus
_ximmunology
650 0 4 _aPoliovirus Vaccine, Inactivated
_ximmunology
650 0 4 _aRabbits
650 0 4 _aRats
650 0 4 _aVaccine Potency
650 0 4 _aVero Cells
700 1 _avan 't Oever, Aart G
700 1 _avan Oijen, Monique G C T
700 1 _aWijffels, René H
700 1 _avan der Pol, Leo A
700 1 _aBakker, Wilfried A M
773 0 _tPloS one
_gvol. 8
_gno. 12
_gp. e83374
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0083374
_zAvailable from publisher's website
999 _c23377985
_d23377985